Back to Search Start Over

An inherited gain-of-function risk allele in EPOR predisposes to familial JAK2 V617F myeloproliferative neoplasms.

Authors :
Rabadan Moraes G
Pasquier F
Marzac C
Deconinck E
Damanti CC
Leroy G
El-Khoury M
El Nemer W
Kiladjian JJ
Raslova H
Najman A
Vainchenker W
Marty C
Bellanné-Chantelot C
Plo I
Source :
British journal of haematology [Br J Haematol] 2022 Jul; Vol. 198 (1), pp. 131-136. Date of Electronic Publication: 2022 Mar 30.
Publication Year :
2022

Abstract

Myeloproliferative neoplasms (MPN) are mainly sporadic but inherited variants have been associated with higher risk development. Here, we identified an EPOR variant (EPOR <superscript>P488S</superscript> ) in a large family diagnosed with JAK2 <superscript>V617F</superscript> -positive polycythaemia vera (PV) or essential thrombocytosis (ET). We investigated its functional impact on JAK2 <superscript>V617F</superscript> clonal amplification in patients and found that the variant allele fraction (VAF) was low in PV progenitors but increase strongly in mature cells. Moreover, we observed that EPOR <superscript>P488S</superscript> alone induced a constitutive phosphorylation of STAT5 in cell lines or primary cells. Overall, this study points for searching inherited-risk alleles affecting the JAK2/STAT pathway in MPN.<br /> (© 2022 British Society for Haematology and John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1365-2141
Volume :
198
Issue :
1
Database :
MEDLINE
Journal :
British journal of haematology
Publication Type :
Academic Journal
Accession number :
35355248
Full Text :
https://doi.org/10.1111/bjh.18165